Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

p8-deficient fibroblasts grow more rapidly and are more resistant to adriamycin-induced apoptosis

Abstract

p8 is a stress-induced DNA-binding protein, biochemically related to the architectural chromatin binding HMG protein family and whose function is presently unknown. We obtained fibroblast from mice lacking p8 and found that p8 is involved in cell growth regulation and in apoptosis. p8−/− mouse embryonic fibroblasts (MEFs) grow more rapidly than p8+/+ MEFs. This might be explained by the higher intracellular level and activity of the Cdk2 and Cdk4 observed in p8−/− MEFs, which in turn may result, at least in part, from the concomitant decrease observed in the amount of cyclin-dependent kinase inhibitor p27. We also report that p8 mRNA expression is strongly activated in fibroblasts after cell growth arrest induced by serum deprivation or confluence. As expected, MEFs expressing p8 arrest their growth more rapidly after serum deprivation than MEFs lacking p8, which strongly suggests that p8 over-expression is implicated in cell growth arrest. On the other hand, p8+/+ MEFs are more sensitive than p8−/− MEFs to the apoptosis induced by adriamycin treatment. p53 might be involved, as p8 expression increases its intracellular amount and trans-activation capacity. Finally, demonstration that p53 is a negative trans-activator of p8 suggests the presence of a complex autoregulatory loop. In conclusion, p8 is a cell growth inhibitor that facilitates apoptosis induced in fibroblasts by DNA damage.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Allen RG, Tresini M . 2000 Free Radic. Biol. Med. 28: 463–499

  • Amundson SA, Myers TG, Fornace AJ . 1998 Oncogene 17: 3287–3299

  • Bratland K, Risberg K, Maelandsmo GM, Gutzkow KB, Olsen OE, Moghaddam A, Wang MY, Hansen CM, Blomhoff HK, Berg JP, Fodstad O, Ree AH . 2000 Cancer Res. 60: 5578–5583

  • Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, Kley N . 1995 Nature 377: 646–649

  • Colman MS, Afshari CA, Barrett JC . 2000 Mutat. Res. 462: 179–188

  • Dameron KM, Volpert OV, Tainsky MA, Bouck N . 1994 Science 265: 1582–154

  • Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS, Bradley A . 1992 Nature 356: 215–321

  • Encinar JA, Mallo GV, Mizyrycki C, Giono L, Gonzalez-Ros JM, Rico M, Canepa E, Moreno S, Neira JL, Iovanna JL . 2001 J. Biol. Chem. 276: 2701–2707

  • Farmer G, Colgan J, Nakatani Y, Manley JL, Prives C . 1996 Mol. Cell. Biol. 16: 4295–4304

  • Garrington TP, Johnson GL . 1999 Curr. Opin. Cell. Biol. 11: 211–218

  • Goldschmidt-Clermont PJ, Moldovan L . 1999 Gene Expr. 7: 255–260

  • Hartwell LH, Kastan MB . 1994 Science 266: 1821–1828

  • Harvey DM, Levine AJ . 1991 Genes Dev. 5: 2375–2385

  • Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A, Donehower LA . 1993 Oncogene 8: 2457–2467

  • Hollstein M, Sidransky D, Vogelstein B, Harris CC . 1991 Science 253: 49–53

  • Ichijo H . 1999 Oncogene 18: 6087–6093

  • Jiang YF, Vaccaro MI, Fiedler F, Calvo EL, Iovanna JL . 1999 Biochem. Biophys. Res. Commun. 260: 686–690

  • Kaufman RJ . 1999 Genes Dev. 13: 1211–1233

  • Ko LJ, Prives C . 1996 Genes Dev. 10: 1054–1072

  • Kuhbandner S, Brummer S, Metzger D, Chambon P, Hofmann F, Feil R . 2000 Genesis. 28: 15–22

  • Mallo GV, Fiedler F, Calvo EL, Ortiz EM, Vasseur S, Keim V, Morisset J, Iovanna JL . 1997 J. Biol. Chem. 272: 32360–32369

  • Martin DW, Munoz RM, Subler MA, Deb S . 1993 J. Biol. Chem. 268: 13062–13067

  • Michalovitz D, Halevy O, Oren M . 1990 Cell 62: 671–680

  • Pesch J, Brehm U, Staib C, Grummt F . 1996 J. Interferon Cytokine Res. 16: 595–600

  • Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B . 1996 Genes Dev. 10: 1945–1952

  • Ragimov N, Krauskopf A, Navot N, Rotter V, Oren M, Aloni Y . 1993 Oncogene 8: 1183–1193

  • Ree AH, Tvermyr M, Engebraaten O, Rooman M, Rosok O, Hovig E, Meza-Zepeda LA, Bruland OS, Fodstad O . 1999 Cancer Res. 59: 4675–4680

  • Sambrook J, Fritsch EF, Maniatis T . 1989 Molecular Cloning: A Laboratory Manual. 2nd edn Plainview, NY: Cold Spring Harbor Lab. Press

    Google Scholar 

  • Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME . 1998 Eur. J. Biochem. 254: 439–459

  • Seed B, Sheen JY . 1988 Gene 67: 271–277

  • Seto E, Usheva A, Zambetti GP, Momand J, Horikoshi N, Weinmann R, Levine AJ, Shenk T . 1992 Proc. Natl. Acad. Sci. USA. 89: 12028–12032

  • Shackelford RE, Kaufmann WK, Paules RS . 1999 Environ Health Perspect. 107: 5–24

  • Stronach BE, Perrimon N . 1999 Oncogene 18: 6172–6182

  • Su SB, Motoo Y, Iovanna JL, Xie MJ, Mouri H, Ohtsubo K, Yamaguchi Y, Watanabe H, Okai T, Matsubara F, Sawabu N . 2001 Clin. Cancer Res. 7: 309–313

  • Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A, Dannenberg AJ . 1999 J. Biol. Chem. 274: 10911–10915

  • Utz PJ, Anderson P . 2000 Cell Death Differ. 7: 589–602

  • Vasseur S, Mallo GV, Fiedler F, Bodeker H, Canepa E, Moreno S, Iovanna JL . 1999a Eur. J. Biochem. 259: 670–675

  • Vasseur S, Mallo GV, Garcia Montero A, Ortiz E, Fiedler F, Canepa E, Moreno S, Iovanna JL . 1999b Biochem. J. 343: 377–383

  • Wang E, Marcotte R, Petroulakis E . 1999 J. Cell. Biochem. 32–33: 95–102

  • Zhai W, Comai L . 2000 Mol. Cell. Biol. 20: 5930–5938

  • Zhang L, Yu D, Hu M, Xiong S, Lang A, Ellis LM, Pollock RE . 2000 Cancer Res. 60: 3655–3661

Download references

Acknowledgements

We thank Drs H Cremer, S Garcia, M Monte and N Dusetti for insightful discussions and critical evaluation of the manuscript and to Dr A Levine for provide us the 10.1 and Val5 cells. Supported by grants from Société de Secours des Amis des Sciences and EMBO short fellowship (S Vasseur), Fondation pour la Recherche Médicale (A Hoffmeister), poste orange INSERM (A Garcia-Montero), and the Humboldt Foundation (GV Mallo). This work was supported by a grant from the Ligue de Lutte Contre le Cancer.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Juan Lucio Iovanna.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vasseur, S., Hoffmeister, A., Garcia-Montero, A. et al. p8-deficient fibroblasts grow more rapidly and are more resistant to adriamycin-induced apoptosis. Oncogene 21, 1685–1694 (2002). https://doi.org/10.1038/sj.onc.1205222

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205222

Keywords

This article is cited by

Search

Quick links